Measurement of in vivo rectal mucosal cytokine and eicosanoid production in ulcerative colitis using filter paper

被引:87
作者
Carty, E
De Brabander, M
Feakins, RM
Rampton, DS
机构
[1] St Bartholomews & Royal London Sch Med & Dent, Digest Dis Res Ctr, London E1 2AD, England
[2] Jan Palfijn Hosp, Janssen Res Fdn, Merksem, Belgium
[3] St Bartholomews & Royal London Sch Med & Dent, Dept Histopathol, London E1 2AD, England
关键词
cytokines; eicosanoids; ulcerative colitis; rectal dialysis;
D O I
10.1136/gut.46.4.487
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background-Excessive mucosal generation of cytokines and eicosanoids has been reported in vitro in ulcerative colitis (UC) using traumatising biopsy techniques, and in vivo using time consuming rectal dialysis. Aims-To validate a simple filter paper technique to profile rectal mucosal production of cytokines and eicosanoids in vivo in patients with UC compared with controls. Patients-Forty one patients with UC (21 with active disease) and 16 controls were studied. Methods-In vitro, recovery of known concentrations of cytokine or mediator applied to filter papers was measured by ELISA following incubation in buffer. In vivo, patients and controls had filter papers apposed to the rectal mucosa briefly through a rigid sigmoidoscope. Filter papers were then incubated prior to assay by ELISA. Results-In vitro validation studies showed that the filter paper technique could be used to measure mucosal release of interleukin-1 beta (IL-1 beta), tumour necrosis factor alpha (TNF-alpha), thromboxane B-2 (TXB2), and prostaglandin E-2 (PGE(2)), but not interferon gamma (IFN-gamma). Mucosal release of IL-1 beta, TNF-alpha, TXB2 and PGE(2) were significantly increased in active uc; (p=0.001) and correlated directly with disease activity (p=0.02). Conclusions-The filter paper technique confirmed increased rectal mucosal release of cytokines and eicosanoids in UC, in proportion to disease activity. The simplicity, safety and speed of the technique make it a practicable option for use in the outpatient clinic to study the pathogenesis of inflammatory bowel disease, and potentially its response to treatment.
引用
收藏
页码:487 / 492
页数:6
相关论文
共 45 条
[1]   VARIATION BETWEEN OBSERVERS IN DESCRIBING MUCOSAL APPEARANCES IN PROCTOCOLITIS [J].
BARON, JH ;
CONNELL, AM ;
LENNARDJONES, JE .
BRITISH MEDICAL JOURNAL, 1964, 1 (5374) :89-+
[2]   STATISTICAL METHODS FOR ASSESSING AGREEMENT BETWEEN TWO METHODS OF CLINICAL MEASUREMENT [J].
BLAND, JM ;
ALTMAN, DG .
LANCET, 1986, 1 (8476) :307-310
[3]  
BLAND M, 1991, INTRO MED STAT, P276
[4]   TUMOR-NECROSIS-FACTOR-ALPHA IN STOOL AS A MARKER OF INTESTINAL INFLAMMATION [J].
BRAEGGER, CP ;
NICHOLLS, S ;
MURCH, SH ;
STEPHENS, S ;
MACDONALD, TT .
LANCET, 1992, 339 (8785) :89-91
[5]   DETECTION OF MESSENGER-RNAS FOR MACROPHAGE PRODUCTS IN INFLAMMATORY BOWEL-DISEASE BY INSITU HYBRIDIZATION [J].
CAPPELLO, M ;
KESHAV, S ;
PRINCE, C ;
JEWELL, DP ;
GORDON, S .
GUT, 1992, 33 (09) :1214-1219
[6]  
Casellas F, 1998, INFLAMM BOWEL DIS, V4, P1
[7]  
CASELLAS F, 1995, EUR J GASTROEN HEPAT, V7, P221
[8]  
Casellas F, 1997, REV ESP ENFERM DIG, V89, P285
[9]   INTRALUMINAL COLONIC RELEASE OF IMMUNOREACTIVE TUMOR-NECROSIS-FACTOR IN CHRONIC ULCERATIVE-COLITIS [J].
CASELLAS, F ;
PAPO, M ;
GUARNER, F ;
ANTOLIN, M ;
ARMENGOL, JR ;
MALAGELADA, JR .
CLINICAL SCIENCE, 1994, 87 (04) :453-458
[10]   Picotamide inhibition of excess in vitro thromboxane B-2 release by colorectal mucosa in inflammatory bowel disease [J].
Collins, CE ;
Benson, MJ ;
Burnham, WR ;
Rampton, DS .
ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 1996, 10 (03) :315-320